Scholte HR, Rodrigues Pereira R, de Jonge PC, Luyt-Houwen IE, Hedwig M, Verduin M, Ross JD: Primary carnitine deficiency
121 Further, this condition would cause cellular and tissue damage, eventually leading to chronic illnesses such as obesity, diabetes, and cancer
Gene Polymorphisms and Low Dietary Intake of Micronutrients in Coronary Artery Disease. Journal of Nutrigenetics and Nutrigenomics, vol
10.1016/j.redox.2015.01.002 140 SiesH
Introduction The Growing Demand for GLP-1 Therapies Current Manufacturing Challenges The Future of GLP-1 Manufacturing Conclusions With the rising global obesity epidemic and the increasing demand for effective weight-loss treatments, the biopharma industry faces mounting pressure to revolutionize GLP-1 manufacturing to meet growing needs efficiently